Navigation Links
UM Clinical Research Building awarded prestigious LEED Building Certification

MIAMI, FL (December 1, 2009)The Clinical Research Building (CRB), at the University of Miami Miller School of Medicine, has been honored for its sustainability components. The building was awarded the LEED designation, established by the U.S. Green Building Council and verified by the Green Building Certification Institute (GBCI). LEED is the nation's preeminent program for the design, construction and operation of green buildings.

"Having a LEED certified building means we're doing our part as a University to be environmentally and socially responsible," says Juan C. Endara, project manager of UM Facilities, Design and Construction. "The LEED certification of the building recognizes those efforts."

The Clinical Research Building on the medical campus achieved LEED certification specifically for its energy use, water and material use, as well as incorporating a variety of other sustainable strategies. By using less energy and water, LEED certified buildings save money for families, businesses and taxpayers; reduce greenhouse gas emissions; and contribute to a healthier environment for residents, workers and the larger community.

"The building meets a high level of performance standards, provides a healthier work environment for the employees and occupants, and costs less to operate and maintain than a non-certified building," Endara says.

LEED Certification of the UM CRB was based on a number of green design and construction features that positively impact the project itself and the broader community. These features include:

  • Use of drought tolerant native shrubs and planting materials resulting in 53 percent reduction of irrigating water consumption.
  • Use of plumbing fixtures that reduce the use of potable water consumption by 30 percent
  • Providing 78 percent of the building's electricity with renewable sources (green power)
  • Use of carpet tiles made with recycled materials and use of adhesives with low emitting gases content
  • An HVAC (heating, ventilating and air conditioning system) designed to conserve energy
  • Implementation of a Green-Cleaning Housekeeping Program

The main purpose of the CRB is to support the continued growth of the UM Miller School of Medicine's clinical research programs and to consolidate current clinical research programs into a single facility. The 15 story, 336,000 square-foot building sits adjacent to SR 836 and I-95, at 1120 NW 14th Street. Its design and construction is consistent with the University of Miami's Green U initiative to become more sustainable through the procurement of environmentally responsible products and environmentally sound maintenance and operations procedures for existing and new buildings.


Contact: Marie Guma-Diaz
University of Miami

Related medicine news :

1. OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
2. Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog
3. Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
4. Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via
5. Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store
6. Baylor Sammons Cancer Center Joins One of Nations Largest Cancer Clinical Trials Groups
7. Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy Therapy
8. Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation
9. Tulane Cancer Center to begin novel clinical trial for late-stage prostate cancer drug
10. Ziosoft Will Showcase New Clinical Functionality and Workflow Optimization Tools for Its Advanced 3D Thin-Client Software at RSNA 2009
11. American Heart Association Late Breaking Clinical Trial Report: In Patients on Statins, Raising Good Cholesterol with Niacin, but not Reducing Bad Cholesterol with Ezetimibe, Decreases Plaque Build-Up
Post Your Comments:
Related Image:
UM Clinical Research Building awarded prestigious LEED Building Certification
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation claim ... of hospital and nonhospital care, according to a recent study by the Workers Compensation ... Edition , found medical payments per claim with more than seven days of lost ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... to continue the expansion of the company’s growing product line of food safety ... (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015—Since ... improvements in scientific research and discoveries, leading us to better understand the disease’s ... to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” provides ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... the 7th Annual 2015 Golden Bridge Business Awards under the New Products and ... zero capex web based sample management software that helps labs organize ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... It’s ... has a tattoo — a number even greater among Millennials (a whopping one in ... are more and more people who are dissatisfied with their ink. In fact, ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 --> ... report "Nucleic Acid Labeling Market by Product (Reagents & ... Primer, In Vitro Transcription, Reverse Transcription, End Labeling), by ... The global market is expected to reach USD 1,925.7 ... growing at a CAGR of 8.65%. Browse ...
(Date:12/1/2015)... 1, 2015 During the recent 2015 ... San Francisco, CA , Medinol Ltd. continued ... marketplace. During a satellite symposium, "The BioNIR eDES: ... Minimize Restenosis", a renowned physician panel discussed the ... CoCr Coronary Stent System and the Medinol eDES ...
(Date:12/1/2015)... N.J. , Dec. 1, 2015 ... against HIV/AIDS, Johnson & Johnson (NYSE: JNJ ... its Janssen Pharmaceutical Companies to significantly reduce the ... who make up 74 percent of new HIV ... Announced on World AIDS Day, these new initiatives ...
Breaking Medicine Technology: